Advertisement
U.S. markets closed

Vor Biopharma Inc. (VOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
0.7900-0.0061 (-0.77%)
At close: 04:00PM EST
0.7900 0.00 (0.00%)
After hours: 05:56PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
117,998
126,036
93,418
69,018
43,366
Operating Income
-117,998
-126,036
-93,418
-69,018
-43,366
Net Non Operating Interest Income Expense
5,535
8,173
1,324
119
29
Other Income Expense
-
-
-
-
-
Pretax Income
-112,463
-117,863
-92,094
-68,899
-43,337
Net Income Common Stockholders
-112,463
-117,863
-92,094
-70,127
-49,262
Diluted NI Available to Com Stockholders
-112,463
-117,863
-92,094
-70,127
-49,262
Basic EPS
-1.89
-1.75
-2.33
-2.10
-1.42
Diluted EPS
-1.89
-1.75
-2.33
-2.10
-1.42
Basic Average Shares
61,595
67,192
39,551
33,433
34,641
Diluted Average Shares
61,595
67,192
39,551
33,433
34,641
Total Operating Income as Reported
-117,998
-126,036
-93,418
-69,018
-43,366
Total Expenses
117,998
126,036
93,418
69,018
43,366
Net Income from Continuing & Discontinued Operation
-112,463
-117,863
-92,094
-68,899
-43,337
Normalized Income
-112,463
-117,863
-92,094
-68,899
-43,337
Interest Income
5,535
8,173
1,324
119
29
Interest Expense
-
-
-
-
0
Net Interest Income
5,535
8,173
1,324
119
29
EBIT
-117,998
-126,036
-93,418
-69,018
-43,366
EBITDA
-114,443
-122,544
-90,893
-67,584
-42,761
Reconciled Depreciation
3,555
3,492
2,525
1,434
605
Net Income from Continuing Operation Net Minority Interest
-112,463
-117,863
-92,094
-68,899
-43,337
Total Unusual Items Excluding Goodwill
-
-
-
-
-
Total Unusual Items
-
-
-
-
-
Normalized EBITDA
-114,443
-122,544
-90,893
-67,584
-42,761
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0